ANTIGEN BINDENDE PROTEINE

Patent europeic · EP4034562 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4034562
Numer da la dumonda
EP20789858
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
25-09-2020
Publitgà
03-08-2022
Concedì
29-10-2025
La protecziun finescha il pli tard
24-09-2040
Proxima taxa annuala scadenta
30-09-2026
Classas IPC
C07K 16/28 (2006.01)
A61P 35/00 (2006.01)
A61K 39/00 (2006.01)
Prioritad
US 201962906876 P 27.09.2019
US 202063057508 P 28.07.2020
Dumonda PCT
PCT/EP2020/076834 25.09.2020
Publicaziun PCT
WO2021/058711 01.04.2021
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 09-09-2026

    Midada

    Published in Swissreg on 09.09.2026

  2. 29-10-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 29.10.2025

Partidas

Possessur

GlaxoSmithKline Intellectual Property Development Limited

GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB

Inventur

DEGENHARDT, Yan Y

Collegeville, Pennsylvania 19426, US

GUAN, Jun

Collegeville, Pennsylvania 19426, US

HANCE, Kenneth William

Collegeville, Pennsylvania 19426, US

MORLEY, Peter Joseph

Stevenage Hertfordshire SG1 2NY, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.